The TGA Has Approved Donanemab for Alzheimer’s Disease. How Does This Drug Work and Who Will Be Able to Access It?
This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease....